Electrode stimulation for spinal cord injury patients is a growing and promising research area. Read more at straitstimes.com ...

Global Medical Electrodes Market is valued approximately USD 1.8 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.6% over the forecast period 2024-2032. Read the ...

The US FDA has granted 510(k) clearance to Neurent Medical's NEUROMARK System for the treatment of individuals with chronic ...

Precision Neuroscience announced today that it has named a new SVP of R&D, along with a new director of medical affairs.

In the past 20 years, substantial progress has been made in the detection and stimulation technology of deep brain neural ...

Neurent Medical announced that it received FDA 510(k) clearance for its next-generation Neuromark system for chronic rhinitis ...

China has become the second country to launch clinical trials for invasive brain-computer interface (BCI) devices in humans.

It feels like I can move at will," said the tetraplegic patient involved in China's first-in-human clinical trial of an ...

China has become the second country in the world to start human trials of its advanced invasive brain-computer interface technology.

Women with fibromyalgia who used a brain stimulation device reduced their pain by 39% on average in a double-blind, sham-controlled, randomized clinical trial.

A recent study published in the Open Access Journal of Sports Medicine reveals that hockey players' cognitive processing ...